IRCT20231109060002N1招募中Unknown
The effectiveness of vitamin D supplementation on schizophrenia symptoms
Yazd University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Diagnosis of chronic outpatient schizophrenia (at least three years have passed since the onset of the disease and at least one year under treatment with antipsychotic drugs) based on DSM5 by a psychiatrist
- •Vitamin D level below 30ng
- •under treatment for at least 8 weeks with a fixed dose of the drug
- •score question (PANSS) above 70
排除标准
- •Received ECT in the past two months
- •Mental retardation
- •Organic brain disease and history of head trauma
- •History of drug and alcohol use
- •Non-cooperation in filling out the questionnaire
- •Non-cooperation in taking medicine or changing its dosage?
- •Non-cooperation in taking vitamin D supplements
- •Kidney, heart, thyroid disorders and diseases, hemorrhagic diseases and malignancies
- •Pregnancy and breastfeeding
研究者
相似试验
已完成
2 期
Effectiveness of vitamin D supplementation on severity of chronic liver diseaseChronic liver disease.Chronic passive congestion of liverIRCT2016020326342N1Vice Chancellor for Research, Mashhad University of Medical Sciences80
已完成
1 期
The efficacy of Vitamin D supplementation in the treatment of schizophreniaSchizophrenia.SchizophreniaIRCT201507087373N5Vice chancer for research , Arak University of Medical Sciences70
招募中
不适用
DPOWER StudyCTRI/2019/01/016921ational Institute of Pharmaceutical Education and ResearchGuwahati
已完成
不适用
Assessment effect of vitamin D supplementation on insulin resistance in women with poly cystic ovarian syndromePolycystic Ovarian Syndrome.Polycystic ovarian syndromeIRCT2014100619426N1Vice chancellor for research, Shahid Beheshti University of Medical Science80
已完成
3 期
The Role of Vitamin D Supplements on Pulmonary Hypertension in Patients with ThalassemiaCondition 1: Pulmonary Hypertension. Condition 2: Thalassemia.Primary pulmonary hypertensionBeta thalassemiaIRCT20190206042644N1Arak University of Medical Sciences28